<DOC>
	<DOCNO>NCT00485823</DOCNO>
	<brief_summary>The purpose study develop weight management program , combine healthy diet , proper physical exercise , behavior modification , related patient 's quality life . The patient group routine practice 5-20 mg olanzapine . The study result may utilized patient gain weight olanzapine also antipsychotic drug .</brief_summary>
	<brief_title>Assessment Weight Management Program Weight Gain Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Weight Gain</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Male female patient age 18 65 year ( inclusive ) Subjects must meet DSMIV criterion schizophrenia , schizoaffective disorder , schizophreniform disorder Subjects must treat olanzapine ( 5 20 mg/day ) least 12 week prior study entry experience weight gain great equal 7 % body weight olanzapine treatment Treatment injectable depot neuroleptic 14 day visit 1 Subjects PANSS score great 70 One seizure without clear unresolved etiology Known diagnosis DSMIV substance dependence ( except nicotine caffeine ) within past 2 month , opinion investigator affect diet and/or weight subject As result liver function test , ALT/AST range show twice upper limit normal reference range</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>